Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

被引：0
|
作者：
Papp, K. [1 ]
Reich, K. [2 ]
Blauvelt, A. [3 ]
Baran, W. [4 ]
Bolduc, C. [5 ,6 ]
Toth, D. [7 ,8 ]
Gottlieb, A. B. [9 ]
Thaci, D. [10 ]
Li, J. [11 ]
Nirula, A. [11 ]
机构：
[1] Prob Med Res, Waterloo, ON, Canada
[2] Dermatologikum Hamburg, Hamburg, Germany
[3] Oregon Med Res Ctr, Portland, OR USA
[4] Wroclaw Med Univ, Wroclaw, Poland
[5] Univ Montreal, Montreal, PQ, Canada
[6] Innovaderm Res, Montreal, PQ, Canada
[7] XLR8 Med Res, Windsor, ON, Canada
[8] Prob Med Res, Windsor, ON, Canada
[9] Tufts Med Ctr, Boston, MA USA
[10] Med Univ Lubeck, D-23538 Lubeck, Germany
[11] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2015年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
043
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study
    Gebauer, Kurt
    Spelman, Lynda
    Yamauchi, Paul S.
    Bagel, Jerry
    Nishandar, Tushar
    Crane, Michael
    Kopeloff, Iris
    Kothekar, Mudgal
    Yao, Siu-Long
    Sofen, Howard L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (01) : 91 - 99
  • [22] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
    Youn, Sang Woong
    Jo, Seong Jin
    Park, Chul Jong
    Kim, Dong Hyun
    Shin, Bong Seok
    Jeong, Ki Heon
    Bang, Chul Hwan
    Cross, Nancy
    Thirlwell, Jackie
    Hoepken, Bengt
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1392 - 1403
  • [23] A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
    Gottlieb, A. B.
    Langley, R. G.
    Strober, B. E.
    Papp, K. A.
    Klekotka, P.
    Creamer, K.
    Thompson, E. H. Z.
    Hooper, M.
    Kricorian, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (03) : 649 - 657
  • [24] Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
    Papp, K. A.
    Langley, R. G.
    Sigurgeirsson, B.
    Abe, M.
    Baker, D. R.
    Konno, P.
    Haemmerle, S.
    Thurston, H. J.
    Papavassilis, C.
    Richards, H. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 412 - 421
  • [25] Phase 1b randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of GLPG3667 in patients with moderate-to-severe plaque psoriasis
    Thaci, Diamant
    Molnar, Judit
    Timmis, Helen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB92 - AB92
  • [26] Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
    Gordon, Kenneth B.
    Foley, Peter
    Krueger, James G.
    Pinter, Andreas
    Reich, Kristian
    Vender, Ronald
    Vanvoorden, Veerle
    Madden, Cynthia
    White, Katy
    Cioffi, Christopher
    Blauvelt, Andrew
    LANCET, 2021, 397 (10273): : 475 - 486
  • [27] Efficacy and safety of ixekizumab in a phaseIII, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)
    Paller, A. S.
    Seyger, M. M. B.
    Alejandro Magarinos, G.
    Bagel, J.
    Pinter, A.
    Cather, J.
    Keller, S.
    Rodriguez Capriles, C.
    Gontijo Lima, R.
    Gallo, G.
    Little, C. A.
    Edson-Heredia, E.
    Li, L.
    Xu, W.
    Papp, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (02) : 231 - 241
  • [28] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Landers, Carol
    Li, Dalin
    Russell, Chris
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Hsu, Yi-Hsiang
    Lin, Shao-Lee
    Klekotka, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607
  • [29] Efficacy and safety of certolizumab pegol, in patients with chronic plaque psoriasis: Preliminary results of a randomized, double-blind, placebo-controlled trial
    Reich, K.
    Tasset, C.
    Ortonne, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 251 - 251
  • [30] Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-blind Trial
    Leonardi, Craig
    Langley, Richard G.
    Papp, Kim
    Tyring, Stephen K.
    Wasel, Norman
    Vender, Ronald
    Unnebrink, Kristina
    Gupta, Shiraz R.
    Valdecantos, Wendell C.
    Bagel, Jerry
    ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 429 - 436
12345